Case File №
#VI-2026-0944
Nexaph
Request Full Data Access to the VendorInvestigate database of peptide tests.
Exhibit I
Compounds on File
44 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Cagrilintide | B Good | 10 | 7.2 | 5.3 | 9.3 | 14 Jun 2025 |
| CJC-1295 | C Okay | 6 | 5.3 | 4.7 | 6.8 | 10 Jun 2025 |
| GHK-Cu | C Okay | 5 | 6.6 | 4.3 | 8.2 | 4 Aug 2025 |
| Semaglutide | C Okay | 14 | 6.2 | 4.5 | 7.5 | 11 Jun 2025 |
| Tesamorelin | D Poor | 21 | 7.0 | 3.2 | 9.7 | 29 Jun 2025 |
| BPC-157 | E Bad | 11 | 6.6 | 1.5 | 9.7 | 29 Jun 2025 |
| Ipamorelin | E Bad | 9 | 5.7 | 0.0 | 8.6 | 3 Jul 2025 |
| Retatrutide | E Bad | 82 | 7.3 | 0.0 | 10.0 | 11 Jun 2025 |
| Tirzepatide | E Bad | 42 | 7.3 | 3.0 | 10.0 | 2 Jul 2025 |
| 17a-Methyl-1-Testosterone | X N/A | 13 | 6.5 | 4.3 | 9.4 | 24 May 2026 |
| Anadrol Oil | X N/A | 5 | 5.0 | 3.5 | 7.4 | 24 May 2026 |
| AOD9604 | X N/A | 2 | 6.0 | 5.2 | 6.7 | 24 May 2026 |
| Arimidex (Anastrozole) | X N/A | 3 | 7.7 | 6.0 | 9.1 | 21 May 2026 |
| BAM15 | X N/A | 9 | 6.9 | 4.6 | 9.2 | 26 Jan 2026 |
| BPC-157 Arg Oral | X N/A | 13 | 7.0 | 3.2 | 9.7 | 17 May 2026 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 6 | 6.5 | 4.8 | 7.7 | 26 Jan 2026 |
| Clenbuterol | X N/A | 12 | 6.7 | 4.1 | 9.6 | 25 May 2026 |
| Dermorphin | X N/A | 7 | 7.1 | 5.5 | 9.0 | 20 May 2026 |
| Dianabol Raw | X N/A | 5 | 7.0 | 5.8 | 8.8 | 20 May 2026 |
| DSIP | X N/A | 5 | 7.2 | 6.0 | 8.3 | 24 May 2026 |
| Estradiol Cypionate | X N/A | 8 | 7.1 | 4.2 | 8.5 | 21 May 2026 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 11 | 6.7 | 3.1 | 9.0 | 21 May 2026 |
| HCG | X N/A | 11 | 7.2 | 3.9 | 9.6 | 19 Jan 2026 |
| LGD-4033 (Ligandrol) Raw | X N/A | 7 | 7.0 | 6.3 | 8.2 | 19 Jan 2026 |
| Lipo-B 216mg | X N/A | 9 | 7.1 | 5.5 | 10.0 | 21 May 2026 |
| Livagen | X N/A | 1 | 6.8 | 6.8 | 6.8 | 11 Jun 2025 |
| Methylstenbolone | X N/A | 9 | 7.5 | 4.0 | 9.3 | 20 May 2026 |
| MGF | X N/A | 4 | 6.4 | 4.9 | 7.5 | 25 May 2026 |
| Minoxidil Oral | X N/A | 6 | 7.7 | 6.4 | 8.6 | 21 May 2026 |
| MOTS-C | X N/A | 7 | 6.7 | 4.3 | 8.9 | 26 Jan 2026 |
| N-Acetyl Epitalon Amidate | X N/A | 2 | 8.1 | 7.1 | 9.2 | 23 May 2026 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 8 | 7.1 | 5.0 | 9.9 | 19 Jan 2026 |
| Ostarine (MK-2866) | X N/A | 9 | 7.0 | 4.7 | 8.6 | 24 May 2026 |
| P21 | X N/A | 11 | 7.6 | 4.6 | 10.0 | 25 May 2026 |
| PE 22-28 | X N/A | 8 | 7.0 | 5.6 | 10.0 | 25 May 2026 |
| PEG MGF | X N/A | 8 | 6.8 | 5.0 | 10.0 | 21 May 2026 |
| PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | X N/A | 8 | 6.2 | 3.1 | 9.2 | 24 May 2026 |
| Proviron (Mesterolone) | X N/A | 11 | 8.0 | 6.0 | 9.9 | 20 May 2026 |
| PTD-DBM | X N/A | 3 | 6.0 | 4.3 | 7.8 | 25 May 2026 |
| S-23 Raw | X N/A | 3 | 5.9 | 5.0 | 7.3 | 26 Jan 2026 |
| SNAP-8 | X N/A | 9 | 7.2 | 5.0 | 10.0 | 24 May 2026 |
| T3 (Liothyronine) | X N/A | 15 | 6.6 | 3.7 | 8.8 | 25 May 2026 |
| Tirzepatide 30mg Pen Kit | X N/A | 4 | 7.8 | 6.0 | 9.0 | 24 May 2026 |
| Trenbolone Acetate Raw | X N/A | 15 | 6.7 | 3.1 | 9.6 | 19 Jan 2026 |
Exhibit II
Evidence Log
274 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 8.4 A | 10mg | 12.0mg | +20.3% | 98.61% | hnuf76 | Lab C | Community |
| 25 May 2026 | Estradiol Cypionate | 7.5 A | 300mg/ml | 366.8mg/ml | +22.3% | 98.88% | naibr7 | Lab F | Public |
| 25 May 2026 | Methylstenbolone | 7.5 A | 20mg | 22.2mg | +10.9% | 98.48% | fy1a9g | Lab B | Community |
| 25 May 2026 | MOTS-C | 6.6 A | 30mg | 31.3mg | +4.2% | 95.12% | u3hhve | Lab A | Public |
| 25 May 2026 | SNAP-8 | 6.9 A | 20mg | 24.1mg | +20.3% | 99.73% | xvwz6l | Lab A | Public |
| 25 May 2026 | Tirzepatide 30mg Pen Kit | 6.7 A | 20mg | 23.6mg | +18.2% | 95.61% | wfl3u7 | Lab C | Public |
| 24 May 2026 | 17a-Methyl-1-Testosterone | 5.4 B | 25mg | 29.9mg | +19.7% | 96.54% | owpdsa | Lab A | Public |
| 24 May 2026 | Clenbuterol | 5.0 B | 20mg | 19.4mg | -2.9% | 98.43% | fw898g | Lab G | Community |
| 24 May 2026 | HCG | 5.5 B | 50mg | 48.3mg | -3.3% | 97.18% | cv9lds | Lab B | Community |
| 24 May 2026 | Proviron (Mesterolone) | 7.9 A | 10mg | 11.8mg | +18.0% | 99.64% | iv1e3u | Lab C | Community |
| 24 May 2026 | BPC-157 | 6.6 B | 10mg | 12.6mglabel | 14.7mg | +17.1% | 99.60% | BPC1001212026-18 | No Label / Red Crimp / Clear Green Cap |
| 24 May 2026 | Tirzepatide | 4.4 D | 30mg | (no batch claim) | 53.4mg | +78.0% | 99.04% | NXP-2P3002072026-01 | No Label / Red Crimp / Blue Cap |
| 24 May 2026 | Arimidex (Anastrozole) | 5.8 B | 10mg | 10.7mg | +7.3% | 95.83% | t744lx | Lab D | Public |
| 24 May 2026 | BPC-157 Arg Oral | 9.9 A | 100mg | 109.7mg | +9.7% | 96.57% | 65wixk | Lab C | Public |
| 24 May 2026 | Dianabol Raw | 6.9 A | 10g | 11.9g | +19.1% | 96.97% | 4piup5 | Lab B | Public |
| 24 May 2026 | Minoxidil Oral | 9.0 A | 25mg | 30.1mg | +20.4% | 98.75% | 5tfb64 | Lab F | Public |
| 24 May 2026 | PE 22-28 | 5.0 B | 50mg | 62.0mg | +24.0% | 96.62% | jqruuw | Lab F | Community |
| 24 May 2026 | PTD-DBM | 5.3 B | 10mg | 10.2mg | +1.7% | 95.51% | cjql3z | Lab D | Public |
| 24 May 2026 | S-23 Raw | 6.6 A | 100g | 89.6g | -10.4% | 96.74% | qtnevw | Lab D | Community |
| 24 May 2026 | Trenbolone Acetate Raw | 4.9 C | 500g | 567.4g | +13.5% | 95.82% | dczfj9 | Lab A | Community |
| 24 May 2026 | Trenbolone Acetate Raw | 8.0 A | 1g | 1.0g | -1.8% | 99.12% | oj0eiw | Lab G | Public |
| 24 May 2026 | Retatrutide | 8.8 A | 12mg | (no batch claim) | 12.9mg | +7.5% | 99.77% | NXP-3P1201092026-01 | (no data) |
| 24 May 2026 | Retatrutide | 9.3 A | 24mg | (no batch claim) | 25.7mg | +7.1% | 99.90% | NXP-3P2401262026-13 | No Label / Black Crimp / Clear Pink Cap |
| 24 May 2026 | Retatrutide | 8.4 A | 24mg | 14.1mglabel | 13.6mg | -3.2% | 99.18% | NXP-3P1201092026-01 | No Label / Green Crimp / Green Cap |
| 24 May 2026 | Dermorphin | 6.7 A | 5mg | 4.9mg | -2.3% | 98.06% | r8zhn4 | Lab A | Community |
| 24 May 2026 | DSIP | 8.3 A | 5mg | 5.7mg | +14.0% | 98.76% | o68abz | Lab B | Public |
| 24 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 7.5 A | 30mg | 35.9mg | +19.6% | 95.66% | rclku9 | Lab F | Public |
| 24 May 2026 | Methylstenbolone | 7.7 A | 100mg | 100.1mg | +0.1% | 99.43% | imij1t | Lab F | Public |
| 24 May 2026 | Methylstenbolone | 6.2 A | 50mg | 45.9mg | -8.2% | 98.46% | jls5zk | Lab G | Public |
| 24 May 2026 | Minoxidil Oral | 7.7 A | 20mg | 18.5mg | -7.3% | 97.78% | 2vu0yw | Lab A | Community |
| 24 May 2026 | Ostarine (MK-2866) | 8.7 A | 100mg | 106.9mg | +6.9% | 96.59% | aehpk4 | Lab F | Public |
| 24 May 2026 | P21 | 7.1 A | 50mg | 58.4mg | +16.7% | 96.54% | 88nqdr | Lab D | Community |
| 24 May 2026 | SNAP-8 | 7.0 A | 5mg | 4.4mg | -12.4% | 97.39% | fmhv2e | Lab B | Community |
| 24 May 2026 | SNAP-8 | 5.5 B | 15mg | 13.7mg | -8.9% | 98.93% | ju3b5q | Lab A | Community |
| 24 May 2026 | Trenbolone Acetate Raw | 4.9 C | 1g | 0.9g | -9.0% | 99.27% | qbtl8m | Lab E | Community |
| 24 May 2026 | Tesamorelin | 8.2 A | 10mg | 11.9mglabel | 11.7mg | -1.5% | 99.11% | TES1001172026-16 | No Label / Silver Crimp / Clear Blue Cap |
| 24 May 2026 | Tirzepatide | 9.3 A | 60mg | 69.9mglabel | 65mg | -7.0% | 99.90% | NXP-2p6001152026-01 | No Label / Red Crimp / Green Cap |
| 24 May 2026 | BAM15 | 8.5 A | 25mg | 24.5mg | -2.0% | 95.93% | bg4tdf | Lab F | Public |
| 24 May 2026 | BPC-157 Arg Oral | 7.4 A | 100mg | 88.6mg | -11.4% | 99.91% | rhddk5 | Lab A | Community |
| 24 May 2026 | BPC-157 Arg Oral | 7.0 A | 50mg | 54.0mg | +8.1% | 95.02% | wjpe90 | Lab F | Public |
| 24 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 5.6 B | 5mg | 5.2mg | +4.3% | 97.60% | on6fw5 | Lab F | Community |
| 24 May 2026 | Clenbuterol | 7.1 A | 20mg | 22.4mg | +12.0% | 99.08% | v8s4l8 | Lab D | Community |
| 24 May 2026 | Methylstenbolone | 7.3 A | 20mg | 21.8mg | +9.2% | 97.14% | 0mauw2 | Lab C | Public |
| 24 May 2026 | MOTS-C | 5.4 B | 5mg | 4.6mg | -8.1% | 99.07% | v2t00x | Lab C | Community |
| 24 May 2026 | MOTS-C | 7.1 A | 5mg | 6.0mg | +19.6% | 95.06% | u9kqnn | Lab D | Community |
| 24 May 2026 | P21 | 9.6 A | 15mg | 16.1mg | +7.0% | 97.18% | 9h3cx5 | Lab G | Community |
| 24 May 2026 | P21 | 7.7 A | 15mg | 13.1mg | -12.7% | 98.22% | jnqk3d | Lab B | Public |
| 24 May 2026 | PEG MGF | 4.8 C | 2mg | 2.0mg | +0.0% | 99.47% | mt6xvn | Lab C | Public |
| 24 May 2026 | Trenbolone Acetate Raw | 7.0 A | 500g | 464.8g | -7.0% | 98.62% | t5ukq0 | Lab A | Public |
| 24 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 6.6 A | 50mg | 43.2mg | -13.6% | 97.40% | g90ohp | Lab C | Public |
| 24 May 2026 | LGD-4033 (Ligandrol) Raw | 8.7 A | 100g | 116.1g | +16.1% | 96.80% | hlryh0 | Lab G | Public |
| 24 May 2026 | Lipo-B 216mg | 7.8 A | 300mg/ml | 281.4mg/ml | -6.2% | 99.88% | 874gi8 | Lab G | Community |
| 24 May 2026 | Methylstenbolone | 8.1 A | 50mg | 46.2mg | -7.6% | 99.46% | vrx489 | Lab E | Public |
| 24 May 2026 | P21 | 8.8 A | 5mg | 4.7mg | -5.0% | 98.20% | hlafvf | Lab A | Community |
| 24 May 2026 | PEG MGF | 7.6 A | 50mg | 56.9mg | +13.9% | 98.98% | 5culml | Lab A | Community |
| 24 May 2026 | Proviron (Mesterolone) | 8.2 A | 25mg | 23.9mg | -4.5% | 96.20% | hbobza | Lab D | Public |
| 24 May 2026 | SNAP-8 | 8.4 A | 50mg | 46.7mg | -6.6% | 99.43% | e0fuah | Lab D | Community |
| 23 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 6.9 A | 10mg | 9.0mg | -9.6% | 99.92% | kk2qm0 | Lab A | Community |
| 23 May 2026 | Clenbuterol | 7.8 A | 20mg | 19.2mg | -3.8% | 95.42% | xhenlj | Lab A | Community |
| 23 May 2026 | DSIP | 5.5 B | 2mg | 2.5mg | +23.6% | 95.64% | wkgnxa | Lab E | Public |
| 23 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.2 A | 2mg | 2.4mg | +20.0% | 98.42% | qohgji | Lab A | Community |
| 23 May 2026 | Ostarine (MK-2866) | 6.4 A | 50mg | 52.9mg | +5.8% | 99.23% | 8zowgz | Lab F | Public |
| 23 May 2026 | PE 22-28 | 6.6 A | 50mg | 43.8mg | -12.4% | 95.68% | 7bre58 | Lab C | Community |
| 23 May 2026 | Proviron (Mesterolone) | 7.6 A | 10mg | 10.5mg | +5.5% | 99.11% | u1uic2 | Lab G | Public |
| 23 May 2026 | SNAP-8 | 8.2 A | 10mg | 8.9mg | -10.8% | 95.83% | 99gcko | Lab C | Community |
| 23 May 2026 | T3 (Liothyronine) | 5.7 B | 100mg | 88.4mg | -11.6% | 98.63% | sye6rx | Lab B | Community |
| 23 May 2026 | T3 (Liothyronine) | 5.5 B | 20mg | 18.7mg | -6.4% | 99.09% | dgeuuw | Lab A | Public |
| 23 May 2026 | 17a-Methyl-1-Testosterone | 5.8 B | 10mg | 8.9mg | -10.6% | 98.67% | luvyej | Lab B | Public |
| 23 May 2026 | Anadrol Oil | 4.0 C | 200mg/ml | 198.3mg/ml | -0.8% | 96.21% | yj068k | Lab C | Public |
| 23 May 2026 | BPC-157 Arg Oral | 5.8 B | 100mg | 95.3mg | -4.7% | 95.90% | 27s9ke | Lab A | Public |
| 23 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 4.6 C | 2mg | 2.4mg | +17.9% | 99.47% | c2tlw3 | Lab B | Public |
| 23 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 5.3 B | 20mg | 17.5mg | -12.4% | 96.75% | psnnfc | Lab A | Community |
| 23 May 2026 | HCG | 6.0 A | 10mg | 8.5mg | -14.7% | 98.32% | 1fe7cf | Lab D | Community |
| 21 May 2026 | 17a-Methyl-1-Testosterone | 5.5 B | 25mg | 25.6mg | +2.6% | 96.69% | co4n0u | Lab D | Community |
| 21 May 2026 | Anadrol Oil | 4.0 C | 250mg/ml | 244.6mg/ml | -2.2% | 99.87% | bbz7v0 | Lab G | Community |
| 21 May 2026 | BPC-157 Arg Oral | 8.3 A | 50mg | 52.8mg | +5.6% | 95.30% | dxltrr | Lab A | Community |
| 21 May 2026 | Dermorphin | 7.3 A | 2mg | 2.0mg | +1.4% | 97.92% | dytcjs | Lab A | Public |
| 21 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 6.1 A | 15mg | 16.4mg | +9.3% | 97.13% | pu8x5b | Lab D | Community |
| 21 May 2026 | HCG | 7.0 A | 20mg | 23.4mg | +17.1% | 98.82% | a410rj | Lab E | Community |
| 21 May 2026 | Lipo-B 216mg | 7.2 A | 200mg/ml | 239.4mg/ml | +19.7% | 97.37% | og4zr1 | Lab A | Public |
| 21 May 2026 | Lipo-B 216mg | 6.2 A | 100mg/ml | 98.9mg/ml | -1.1% | 95.55% | yl1yu5 | Lab A | Public |
| 21 May 2026 | Lipo-B 216mg | 7.8 A | 200mg/ml | 210.0mg/ml | +5.0% | 99.99% | 8h0r5j | Lab F | Community |
| 21 May 2026 | MOTS-C | 5.9 B | 30mg | 30.6mg | +1.8% | 96.05% | fyjlxk | Lab G | Public |
| 21 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 8.1 A | 30mg | 26.3mg | -12.4% | 96.23% | f4t8ux | Lab B | Community |
| 21 May 2026 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 4.3 C | 10g | 12.4g | +24.0% | 99.94% | dm8mzo | Lab E | Community |
| 21 May 2026 | Proviron (Mesterolone) | 9.4 A | 10mg | 9.2mg | -7.5% | 97.64% | j6gok9 | Lab D | Community |
| 21 May 2026 | S-23 Raw | 7.9 A | 500g | 505.2g | +1.0% | 96.46% | aqdj90 | Lab D | Community |
| 21 May 2026 | Trenbolone Acetate Raw | 6.4 A | 5g | 5.2g | +3.7% | 98.58% | 3qvcwt | Lab F | Community |
| 21 May 2026 | Arimidex (Anastrozole) | 8.9 A | 100mg | 88.3mg | -11.7% | 98.22% | 4fmb60 | Lab F | Public |
| 21 May 2026 | Clenbuterol | 4.9 C | 50mg | 50.3mg | +0.6% | 98.65% | n7js60 | Lab F | Public |
| 21 May 2026 | HCG | 8.1 A | 30mg | 33.7mg | +12.3% | 97.70% | x3x6lt | Lab D | Community |
| 21 May 2026 | Lipo-B 216mg | 9.3 A | 250mg/ml | 248.4mg/ml | -0.6% | 99.15% | 8zybg5 | Lab C | Public |
| 21 May 2026 | PEG MGF | 7.5 A | 20mg | 18.5mg | -7.5% | 96.24% | 6utax1 | Lab F | Public |
| 21 May 2026 | Proviron (Mesterolone) | 8.4 A | 20mg | 19.5mg | -2.5% | 96.59% | aza7r1 | Lab C | Community |
| 21 May 2026 | Trenbolone Acetate Raw | 4.5 C | 100g | 106.0g | +6.0% | 97.54% | ve7d4x | Lab E | Public |
| 21 May 2026 | Trenbolone Acetate Raw | 7.2 A | 500g | 485.2g | -3.0% | 97.47% | eh0csd | Lab D | Public |
| 20 May 2026 | 17a-Methyl-1-Testosterone | 4.0 C | 50mg | 57.0mg | +14.0% | 97.48% | 83om5e | Lab C | Public |
| 20 May 2026 | BAM15 | 5.0 B | 100mg | 92.8mg | -7.2% | 99.70% | q2mt38 | Lab E | Public |
| 20 May 2026 | BAM15 | 4.8 C | 100mg | 95.1mg | -4.9% | 98.48% | pwyplx | Lab C | Community |
| 20 May 2026 | BPC-157 Arg Oral | 5.5 B | 25mg | 22.7mg | -9.2% | 98.41% | 765fdf | Lab D | Community |
| 20 May 2026 | Dermorphin | 8.5 A | 10mg | 8.7mg | -13.2% | 99.90% | vamc2l | Lab E | Public |
| 20 May 2026 | LGD-4033 (Ligandrol) Raw | 6.2 A | 100g | 87.4g | -12.6% | 99.86% | euazo2 | Lab C | Public |
| 20 May 2026 | Minoxidil Oral | 7.3 A | 50mg | 59.6mg | +19.3% | 96.58% | 1vmuqc | Lab A | Public |
| 20 May 2026 | MOTS-C | 8.7 A | 5mg | 5.7mg | +14.7% | 99.96% | 6jnb14 | Lab D | Public |
| 20 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 6.7 A | 50mg | 51.7mg | +3.4% | 98.58% | ovvq4y | Lab F | Public |
| 20 May 2026 | Ostarine (MK-2866) | 9.7 A | 10mg | 11.3mg | +13.1% | 95.27% | 94uoj5 | Lab E | Public |
| 19 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 4.3 C | 30mg | 28.0mg | -6.5% | 99.03% | k9bsc5 | Lab D | Public |
| 19 May 2026 | Clenbuterol | 6.7 A | 100mg | 121.0mg | +21.0% | 96.74% | tmovms | Lab E | Community |
| 19 May 2026 | Estradiol Cypionate | 6.4 A | 100mg/ml | 95.7mg/ml | -4.3% | 98.83% | tcfsry | Lab F | Community |
| 19 May 2026 | HCG | 6.0 A | 10mg | 10.7mg | +7.0% | 96.59% | psa3ac | Lab G | Public |
| 19 May 2026 | Lipo-B 216mg | 6.1 A | 100mg/ml | 86.3mg/ml | -13.7% | 97.20% | oz3196 | Lab D | Public |
| 19 May 2026 | PEG MGF | 6.7 A | 15mg | 14.5mg | -3.1% | 98.84% | z6c50u | Lab F | Public |
| 19 May 2026 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 8.8 A | 1g | 1.1g | +9.1% | 98.77% | qq0e6z | Lab G | Public |
| 19 May 2026 | Proviron (Mesterolone) | 8.2 A | 25mg | 25.7mg | +2.9% | 98.92% | humhqv | Lab F | Public |
| 19 May 2026 | PTD-DBM | 5.8 B | 5mg | 5.2mg | +3.2% | 99.93% | n2iih2 | Lab D | Community |
| 19 May 2026 | T3 (Liothyronine) | 6.3 A | 20mg | 24.8mg | +24.1% | 98.68% | ebb8yk | Lab G | Community |
| 19 May 2026 | Trenbolone Acetate Raw | 5.4 B | 1g | 0.9g | -7.1% | 97.14% | rjkllw | Lab B | Community |
| 17 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 5.0 B | 2mg | 2.2mg | +10.3% | 97.67% | 4i87yy | Lab B | Public |
| 17 May 2026 | Estradiol Cypionate | 5.6 B | 300mg/ml | 317.4mg/ml | +5.8% | 95.92% | cx5216 | Lab B | Community |
| 17 May 2026 | HCG | 5.8 B | 15mg | 15.6mg | +3.9% | 96.57% | gku7w1 | Lab A | Community |